established an investment and development partnership enterprise in Wuhan with a total investment of 3.15 billion yuan.

App shows that recently, CMB Life Sciences Investment Development Partnership Enterprise was established, with CMB Life Sciences Investment Co., Ltd. as the executive partner. The total investment amount is approximately 3.15 billion RMB, and the business scope is to engage in investment activities with its own funds. The equity panorama penetration chart shows that the partnership enterprise is jointly invested by CMB Innovation Technology Co., Ltd. under CMB Group, CMB Life Sciences Co., Ltd., and Wuhan Shiyu Enterprise Management Co., Ltd.